Expert-led GLP-1 receptor agonist prescribing training for independent nurse prescribers, doctors and pharmacists in private practice — with governance frameworks, SOPs and clinical supervision.
Join Membership Enquire NowGLP-1 Prescribing Training
GLP-1 receptor agonists — including Mounjaro (tirzepatide), Wegovy (semaglutide) and Saxenda (liraglutide) — represent the most significant development in weight management pharmacotherapy in a generation. For independent prescribers in private practice, safe and effective GLP-1 prescribing requires both clinical competence and a robust clinical governance framework.
Our GLP-1 prescribing training is developed by experienced clinicians and aligned to the latest MHRA guidance, NICE technology appraisals and UK prescribing standards. It is available as part of The Compliance Clinic Membership, alongside obesity management training, governance resources and clinical supervision.
Mechanism of action as a dual GIP/GLP-1 receptor agonist, licensed indications, dosing, monitoring and governance.
Wegovy prescribing for weight management — patient selection, dosing schedules, monitoring and side effect management.
Saxenda prescribing guidance including patient eligibility, titration, monitoring and clinical governance requirements.
Evidence-based patient selection criteria, contraindications, cautions and shared decision-making frameworks.
Baseline assessment, ongoing monitoring requirements, safety checks and escalation pathways.
SOPs, consent documentation, clinical audit tools and governance frameworks for GLP-1 prescribing services.
Prescribing GLP-1 medicines in private practice requires a robust clinical governance framework. Our membership provides all the governance documentation you need — including patient selection SOPs, prescribing protocols, consent forms, monitoring checklists, medicines safety processes and clinical audit tools — all written by experienced healthcare compliance specialists and aligned to current regulatory requirements.
Mounjaro (tirzepatide), Wegovy (semaglutide), Saxenda (liraglutide) and other GLP-1 receptor agonists approved for weight management and type 2 diabetes in the UK.
Yes. Dedicated Mounjaro (tirzepatide) training covers its mechanism of action as a dual GIP and GLP-1 receptor agonist, licensed indications, patient selection, dosing, monitoring and prescribing governance.
Yes. Prescribing GLP-1 medicines in private practice requires patient selection SOPs, prescribing protocols, consent documentation, monitoring protocols, medicines safety processes and clinical audit. Our membership provides all the governance documentation you need.
Yes. Our GLP-1 prescribing training is CPD accredited and contributes to NMC revalidation, GMC appraisal and GPhC CPD requirements.
Join The Compliance Clinic Membership for expert-led GLP-1 prescribing training, governance frameworks, SOPs and clinical supervision.
Join MembershipEnquire Now